nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—peripheral nervous system neoplasm	0.537	1	CbGaD
Terazosin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0511	0.239	CbGbCtD
Terazosin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0511	0.239	CbGbCtD
Terazosin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0354	0.166	CbGbCtD
Terazosin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0218	0.102	CbGbCtD
Terazosin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0203	0.0953	CbGbCtD
Terazosin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.02	0.0937	CbGbCtD
Terazosin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.0639	CbGbCtD
Terazosin—Doxazosin—ABCB1—peripheral nervous system neoplasm	0.00115	0.52	CrCbGaD
Terazosin—Prazosin—ABCB1—peripheral nervous system neoplasm	0.00106	0.48	CrCbGaD
Terazosin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00114	CcSEcCtD
Terazosin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Pain—Vincristine—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00114	CcSEcCtD
Terazosin—Rash—Melphalan—peripheral nervous system neoplasm	0.00028	0.00113	CcSEcCtD
Terazosin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00028	0.00113	CcSEcCtD
Terazosin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00113	CcSEcCtD
Terazosin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000278	0.00112	CcSEcCtD
Terazosin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00112	CcSEcCtD
Terazosin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00112	CcSEcCtD
Terazosin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00112	CcSEcCtD
Terazosin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00112	CcSEcCtD
Terazosin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000274	0.00111	CcSEcCtD
Terazosin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000271	0.0011	CcSEcCtD
Terazosin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.0011	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.0011	CcSEcCtD
Terazosin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000271	0.0011	CcSEcCtD
Terazosin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00109	CcSEcCtD
Terazosin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00109	CcSEcCtD
Terazosin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000269	0.00109	CcSEcCtD
Terazosin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000269	0.00109	CcSEcCtD
Terazosin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00109	CcSEcCtD
Terazosin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000268	0.00109	CcSEcCtD
Terazosin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000267	0.00108	CcSEcCtD
Terazosin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000267	0.00108	CcSEcCtD
Terazosin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000266	0.00108	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00107	CcSEcCtD
Terazosin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000264	0.00107	CcSEcCtD
Terazosin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000264	0.00107	CcSEcCtD
Terazosin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00106	CcSEcCtD
Terazosin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00106	CcSEcCtD
Terazosin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00106	CcSEcCtD
Terazosin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000261	0.00105	CcSEcCtD
Terazosin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00026	0.00105	CcSEcCtD
Terazosin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00026	0.00105	CcSEcCtD
Terazosin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00026	0.00105	CcSEcCtD
Terazosin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000259	0.00105	CcSEcCtD
Terazosin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000257	0.00104	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00104	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00103	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00103	CcSEcCtD
Terazosin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000254	0.00103	CcSEcCtD
Terazosin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00102	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00102	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000252	0.00102	CcSEcCtD
Terazosin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00102	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00102	CcSEcCtD
Terazosin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000249	0.00101	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00101	CcSEcCtD
Terazosin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000248	0.001	CcSEcCtD
Terazosin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000992	CcSEcCtD
Terazosin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00099	CcSEcCtD
Terazosin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000982	CcSEcCtD
Terazosin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000982	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00098	CcSEcCtD
Terazosin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000242	0.000979	CcSEcCtD
Terazosin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.000976	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000969	CcSEcCtD
Terazosin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000968	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000239	0.000967	CcSEcCtD
Terazosin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000966	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000237	0.00096	CcSEcCtD
Terazosin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000237	0.000957	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000957	CcSEcCtD
Terazosin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000236	0.000954	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.000946	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000944	CcSEcCtD
Terazosin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.000944	CcSEcCtD
Terazosin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000232	0.000938	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000231	0.000936	CcSEcCtD
Terazosin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000929	CcSEcCtD
Terazosin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000229	0.000928	CcSEcCtD
Terazosin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000922	CcSEcCtD
Terazosin—Pain—Etoposide—peripheral nervous system neoplasm	0.000228	0.000921	CcSEcCtD
Terazosin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000228	0.000921	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00092	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00092	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000918	CcSEcCtD
Terazosin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.000912	CcSEcCtD
Terazosin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000225	0.000909	CcSEcCtD
Terazosin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000907	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000907	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000896	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000894	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000893	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000888	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000219	0.000887	CcSEcCtD
Terazosin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.000884	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000218	0.00088	CcSEcCtD
Terazosin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000217	0.000879	CcSEcCtD
Terazosin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000877	CcSEcCtD
Terazosin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00087	CcSEcCtD
Terazosin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.000869	CcSEcCtD
Terazosin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000866	CcSEcCtD
Terazosin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.000864	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000853	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000852	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00021	0.000851	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00021	0.000851	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000851	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000851	CcSEcCtD
Terazosin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000209	0.000845	CcSEcCtD
Terazosin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000208	0.000843	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000843	CcSEcCtD
Terazosin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000839	CcSEcCtD
Terazosin—Rash—Vincristine—peripheral nervous system neoplasm	0.000207	0.000838	CcSEcCtD
Terazosin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000207	0.000837	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000837	CcSEcCtD
Terazosin—Headache—Vincristine—peripheral nervous system neoplasm	0.000206	0.000833	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000826	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000821	CcSEcCtD
Terazosin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000819	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000819	CcSEcCtD
Terazosin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000199	0.000804	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000794	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000196	0.000793	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000792	CcSEcCtD
Terazosin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000195	0.000789	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000788	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00078	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000774	CcSEcCtD
Terazosin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000191	0.000772	CcSEcCtD
Terazosin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000188	0.000762	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000759	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000757	CcSEcCtD
Terazosin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000747	CcSEcCtD
Terazosin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000741	CcSEcCtD
Terazosin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00074	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000739	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000182	0.000737	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000735	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000733	CcSEcCtD
Terazosin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000729	CcSEcCtD
Terazosin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000726	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000724	CcSEcCtD
Terazosin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000718	CcSEcCtD
Terazosin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000715	CcSEcCtD
Terazosin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000176	0.000712	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000702	CcSEcCtD
Terazosin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000698	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000697	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000686	CcSEcCtD
Terazosin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000169	0.000685	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000684	CcSEcCtD
Terazosin—Rash—Etoposide—peripheral nervous system neoplasm	0.000168	0.000679	CcSEcCtD
Terazosin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000168	0.000678	CcSEcCtD
Terazosin—Headache—Etoposide—peripheral nervous system neoplasm	0.000167	0.000674	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000674	CcSEcCtD
Terazosin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000671	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00067	CcSEcCtD
Terazosin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000667	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000665	CcSEcCtD
Terazosin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000664	CcSEcCtD
Terazosin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000663	CcSEcCtD
Terazosin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000662	CcSEcCtD
Terazosin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000653	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00065	CcSEcCtD
Terazosin—Cough—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000645	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000645	CcSEcCtD
Terazosin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000641	CcSEcCtD
Terazosin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000158	0.00064	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000635	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00063	CcSEcCtD
Terazosin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00063	CcSEcCtD
Terazosin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00063	CcSEcCtD
Terazosin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000627	CcSEcCtD
Terazosin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000622	CcSEcCtD
Terazosin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000617	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000616	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000615	CcSEcCtD
Terazosin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000614	CcSEcCtD
Terazosin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000609	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000605	CcSEcCtD
Terazosin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000604	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000604	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000601	CcSEcCtD
Terazosin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000597	CcSEcCtD
Terazosin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000594	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000593	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000591	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000589	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000583	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000583	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000583	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000583	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00058	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000576	CcSEcCtD
Terazosin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000575	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00057	CcSEcCtD
Terazosin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000564	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000563	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000558	CcSEcCtD
Terazosin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000558	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00055	CcSEcCtD
Terazosin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000549	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000547	CcSEcCtD
Terazosin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000546	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000545	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000542	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00054	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000538	CcSEcCtD
Terazosin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000537	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000532	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000531	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000525	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000522	CcSEcCtD
Terazosin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00052	CcSEcCtD
Terazosin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000516	CcSEcCtD
Terazosin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000516	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000509	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000505	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000501	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000498	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000497	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000496	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000493	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000492	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000485	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000481	CcSEcCtD
Terazosin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000478	CcSEcCtD
Terazosin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000478	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000477	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000477	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00046	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000457	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000445	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000441	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000441	CcSEcCtD
Terazosin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000433	CcSEcCtD
Terazosin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000427	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000413	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000411	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000401	CcSEcCtD
Terazosin—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000399	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000395	CcSEcCtD
Terazosin—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000384	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000382	CcSEcCtD
Terazosin—Rash—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000381	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.00038	CcSEcCtD
Terazosin—Headache—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000378	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000369	CcSEcCtD
Terazosin—Nausea—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000358	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000355	CcSEcCtD
Terazosin—Rash—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000352	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000352	CcSEcCtD
Terazosin—Headache—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.00035	CcSEcCtD
Terazosin—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000332	CcSEcCtD
